Sun Pharma acquires rights to trademarks of three diabetes drug brands in India from AstraZeneca

"Sun Pharma has now acquired the rights to trademarks Oxra, Oxramet and Oxraduo in India from AstraZeneca AB, Sweden, parent company of AstraZeneca Pharma India Limited, with effect from May 28, 2021," Sun Pharma said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fv08pc
via IFTTT